Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index; 68 of the 92 sources its claims cite were checked for support.

Revolutionizing dermatopathology using AI in skin diagnostics: scoping review

Open access
Rammal, Rawan, Mohy U Din, Ahmad, Alam, Tanvir · 2026 · Frontiers in Medicine

Abstract

AI models are becoming is increasingly used to enhance skin disease diagnosis and treatment. This scoping review complies with the PRISMA-ScR guidelines and after considering the inclusion and exclusion criteria, 12 articles published between 2017 and 2024 were considered. Majority of the publications are published from US and China. Among the selected studies, CNN- and ViT-based AI models were the most commonly used in literature, while LLM-based models (such as SkinGPT and Gemini-based models) appear in recently times more frequently to conduct interactive analysis for users. Recent studies have increasingly featured LLM-based models (e.g., SkinGPT, Gemini), indicating their growth as novel architectures in contrast to traditional CNN and ViT approaches. Among the diseases, the studied mainly covered melanoma, nevi, basal cell carcinoma, keratinocyte carcinoma, seborrheic keratosis, colorectal adenoma, etc. Our research reveals that while AI models excel in diagnosing prevalent and well-documented skin problems, their diagnostic efficacy significantly diminishes for rare or underrepresented diseases, highlighting the necessity for more robust, diversified, and clinically validated models. AI models are often too generic for multiple skin diseases. The studies utilized both private clinical data and public accessible resources, including ISIC and MoleMap. Majority of the AI models need improved clinical validation and regulatory standards covering ethical and legal standards to be considered as a tool for healthcare service providers. Despite these constraints, the reviewed studies indicate that AI models can enhance dermatopathology by increasing lesion classification precision, facilitating early detection, and reducing diagnostic strain; underscoring their prospective significance for clinicians and patients.

Overview

CoChat Summary

TL;DR

This scoping review mapped AI use in dermatopathology from 2017–2024 and included 12 studies. It finds strong performance in curated settings, but recurring drops in real-world or whole-slide use, with major concerns around external validation, dataset diversity, and explainability.

Key findings

  • The review screened 120 records and included 12 articles; 7 of the included studies were quantitative and 5 were mixed-methods.
  • Across the included literature, AI was used mainly for diagnostic tasks such as lesion classification and detection, with fewer studies on decision support, patient engagement, and report generation.
  • Reported performance varied by model and setting: GPT-4 had 74% sensitivity and 36% specificity in one cited histopathology task; CNNs were reported at 99% accuracy on curated datasets but 92% on whole-slide images with 85% sensitivity and 99% specificity; SkinGPT-4 achieved 78.76% accuracy on 150 real-life cases.
  • The paper reports stronger results for some models on selected tasks, including ResNet50 with F1 0.93, sensitivity 0.92, specificity 0.97, and AUC 0.99 for melanoma detection, and DVFNet with AUC 98.32% on ISIC 2019.

Methods

  • Scoping review conducted according to PRISMA-ScR; the review question focused on the current state of AI in dermatopathology for skin disease diagnosis.
  • Searches were run in November 2024 in PubMed, ScienceDirect, and arXiv, covering English-language papers published from 2017 to 2024, with manual reference-list searching.
  • Two reviewers screened studies using PICO-based eligibility criteria; 120 records were identified, 47 full texts were assessed, and 12 studies were included.

Limitations

  • The paper states that many included studies lacked external validation, relied on curated datasets, and underrepresented rare disease classes; it also notes limited information on cost-effectiveness, ethics, and patient outcomes.
  • It further states that the review is constrained by the scoping-review approach and does not perform experiments itself, so it cannot replicate or directly test the included models.
  • Evident from the text: the evidence base is small and heterogeneous (12 studies across multiple model families, diseases, and metrics), which makes direct comparison difficult; this is implied by the synthesis rather than explicitly stated.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fmed.2026.1614681

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Study selection process using PRISMA guideline.
Figure 1 Study selection process using PRISMA guideline.CC BY · PubMed Central
Figure 2 Country representation for the selected studies.
Figure 2 Country representation for the selected studies.CC BY · PubMed Central

Verification

Claims the paper makes

51 Valid · 6 Not valid · 22 Not checked · 55 Own results and interpretations

39 more claims · 13 with their cited sources checked

Create a free account to see all 134 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 47
  • It may state two separate claims as one. 62

Create a free account to see these claims.

Citations

Cites

Show all 35 references

Research works printed but not linked: 1

  1. Mallikarjunaradhya, 2023, The optimized analysis for early detection of skin cancer using artificial intelligence, IJCRT, 11, c180

Cited by

See all 1

Metadata

Authors
Rammal, R., Mohy U Din, A., & Alam, T.
Affiliations
  • Hamad bin Khalifa University (QA)
  • College of Science and Engineering, Hamad Bin Khalifa University
Corresponding author
Alam, Tanvir
Venue
Frontiers in Medicine
Published
2026-02-19
Volume
13
Pages
1614681-1614681
ISSN
2296-858X (ISSN-L)
OpenAlex
W7130517804
Cited by
1
References
35
Citations by year
2026: 1
FWCI
0.84
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Medicine (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Hamad Bin Khalifa University
  • Khalifa University of Science, Technology and Research
  • College of Science and Engineering, University of Minnesota
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
dermatological diagnosis, convolutional neural networks, vision transformer, large language models, melanoma, basal cell carcinoma, non-melanoma skin cancer, seborrheic keratosis, nevi, colorectal adenoma, lesion classification, early detection, ISIC, clinical validation, regulatory standards

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Revolutionizing dermatopathology using AI in skin diagnostics: scoping review. https://app.cochat.ai/papers/10.3389/fmed.2026.1614681
The paper
Rammal, R., Mohy U Din, A., & Alam, T. (2026). Revolutionizing dermatopathology using AI in skin diagnostics: scoping review. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1614681

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.